The effect of docetaxel on developing oedema in patients with breast cancer: a systematic review

Author:

Hugenholtz-Wamsteker W.12,Robbeson C.13,Nijs J.1456,Hoelen W.1,Meeus M.1478

Affiliation:

1. European College for Lymphology & Oncology; De Berekuyl/CSI-the Netherlands; Hierden the Netherlands

2. Procare Fysiotherapie & Trainingscentrum; Gorinchem the Netherlands

3. Fysiotherapie Heuts; Dinteloord the Netherlands

4. Pain in Motion International Research Group (www.paininmotion.be); Brussels Belgium

5. Departments of Human Physiology & Physiotherapy; Faculty of Physical Education & Physiotherapy; Vrije Universiteit Brussel; Brussels Belgium

6. Department of Physical Medicine and Physiotherapy; University Hospital Brussels; Brussels Belgium

7. Department of Rehabilitation Sciences and Physiotherapy; Faculty of Medicine & Health Sciences; Ghent University; Ghent Belgium

8. Department of Rehabilitation Sciences and Physiotherapy; Faculty of Medicine & Health Sciences; University of Antwerp; Antwerp Belgium

Funder

European College for Decongestive Lymphatic Therapy, the Netherlands

Vrije Universiteit Brussel

Publisher

Wiley

Subject

Oncology

Reference19 articles.

1. Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study;Andersson;Journal of Clinical Oncology,2011

2. Docetaxel-related side effects and their management;Baker;European Journal of Oncology Nursing,2009

3. The pathophysiological mechanism of fluid retention in advanced cancer patients treated with docetaxel, but not receiving corticosteroid comedication;Behar;British Journal of Clinical Pharmacology,1997

4. Weekly paclitaxel versus weekly docetaxel in elderly or frail patients with metastatic breast carcinoma: a randomized phase-II study of the Belgian Society of Medical Oncology;Beuselinck;Critical Reviews in Oncology,2010

5. Ferlay J. Soerjomataram I. Ervik M. Dikshit R. Eser S. Mathers C. Rebelo M. Parkin D.M. Forman D. Bray F. 2013 GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] http://globocan.iarc.fr

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3